Wuxi School of Medicine, Jiangnan University, Wuxi, China (Y.Z., Y.C., S.W., L.F., F.Y., X.M.).
Department of Vascular Surgery, Affiliated Hospital of Jiangnan University, Wuxi, China (J.T., H.L.).
Hypertension. 2023 Apr;80(4):757-770. doi: 10.1161/HYPERTENSIONAHA.122.20109. Epub 2023 Feb 16.
BACKGROUND: Vascular endothelium and smooth muscle work together to keep the balance of vasomotor tone and jointly maintain vascular homeostasis. Ca-permeable ion channel TRPV4 (transient receptor potential vanilloid family member 4) in endothelial cells regulates endothelium-dependent vasodilation and contraction in various states. However, how vascular smooth muscle cell TRPV4 (TRPV4) contributes to vascular function and blood pressure regulation in physiological and pathologically obese condition has not been fully studied. METHODS: We generated smooth muscle TRPV4-deficient mice and developed diet-induced obese mice model and analyzed the role of TRPV4 in intracellular Ca ([Ca]) regulation and vasoconstriction. Vasomotor changes of mouse mesenteric artery were measured by wire, and pressure myography. [Ca] were measured by fluo-4 staining. Blood pressure was recorded by telemetric device. RESULTS: Vascular TRPV4 played different roles in regulating vasomotor tone than endothelial TRPV4 due to their different features of [Ca] regulation. Loss of TRPV4 attenuated U46619- and phenylephrine-induced contraction, suggesting its involvement in regulating vascular contractility. Mesenteric arteries from obese mice showed SMC hyperplasia, suggesting an increased level of TRPV4. Loss of TRPV4 did not influence the development of obesity but protected mice from obesity-induced vasoconstriction and hypertension. In arteries deficient in SMC TRPV4, SMCs F-actin polymerization and RhoA dephosphorylation were attenuated under contractile stimuli. Moreover, SMC-dependent vasoconstriction was inhibited in human resistance arteries with TRPV4 inhibitor application. CONCLUSIONS: Our data identify TRPV4 as a regulator of vascular contraction in both physiological states and pathologically obese mice. TRPV4 contributes to the ontogeny of vasoconstriction and hypertension induced by TRPV4 over-expression in obese mice mesenteric artery.
背景:血管内皮细胞和平滑肌共同作用以保持血管舒缩张力的平衡,并共同维持血管内环境稳定。内皮细胞中的钙通透性离子通道 TRPV4(瞬时受体电位香草酸家族成员 4)调节各种状态下的内皮依赖性血管舒张和收缩。然而,血管平滑肌细胞 TRPV4(TRPV4)在生理和病理肥胖状态下如何影响血管功能和血压调节尚未得到充分研究。
方法:我们生成了平滑肌 TRPV4 缺陷型小鼠,并建立了饮食诱导肥胖小鼠模型,分析了 TRPV4 在细胞内钙 ([Ca]) 调节和血管收缩中的作用。通过线测量法和压力肌描记法测量小鼠肠系膜动脉的血管舒缩变化。通过 fluo-4 染色测量 [Ca]。通过遥测装置记录血压。
结果:由于 [Ca] 调节的特征不同,血管 TRPV4 在调节血管舒缩张力方面的作用与内皮 TRPV4 不同。TRPV4 的缺失减弱了 U46619 和苯肾上腺素诱导的收缩,表明其参与调节血管收缩性。肥胖小鼠的肠系膜动脉显示出平滑肌细胞增生,提示 TRPV4 水平增加。TRPV4 的缺失不影响肥胖的发展,但可保护肥胖小鼠免于肥胖诱导的血管收缩和高血压。在缺乏平滑肌 TRPV4 的动脉中,收缩刺激下平滑肌细胞 F-肌动蛋白聚合和 RhoA 去磷酸化减弱。此外,在人阻力动脉中应用 TRPV4 抑制剂可抑制依赖平滑肌的血管收缩。
结论:我们的数据确定 TRPV4 是生理状态和病理肥胖小鼠血管收缩的调节因子。TRPV4 有助于肥胖小鼠肠系膜动脉中 TRPV4 过表达诱导的血管收缩和高血压的发生。
Circulation. 2022-8-16
Am J Physiol Heart Circ Physiol. 2009-9
Eur J Pharmacol. 2019-7-18
J Physiol. 2025-7
Nat Rev Cardiol. 2025-5-28
Inflamm Regen. 2024-12-27
Hypertens Res. 2024-12
Drug Discov Today. 2024-7